Cleared Traditional

K980312 - NOVA LITE ENDOMYSIAL (FDA 510(k) Clearance)

Apr 1998
Decision
65d
Days
Class 2
Risk

K980312 is an FDA 510(k) clearance for the NOVA LITE ENDOMYSIAL. This device is classified as a Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control (Class II - Special Controls, product code DBL).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on April 2, 1998, 65 days after receiving the submission on January 27, 1998.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K980312 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1998
Decision Date April 02, 1998
Days to Decision 65 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code DBL — Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660